GM1 ganglioside-integrin complex (GM1-integrin)

The GM1 ganglioside-integrin complex on effector T cells is a specialized membrane assembly consisting of the monosialotetrahexosylganglioside (GM1) and various integrins, most notably LFA-1 (CD11a/CD18) and alpha5beta1. This complex is primarily localized within lipid rafts and serves as the functional receptor for Galectin-1, an endogenous lectin that regulates immune homeostasis. Upon binding to the carbohydrate motifs of the GM1-integrin complex, Galectin-1 triggers a signaling cascade involving the redistribution of glycoproteins like CD45 and CD7, ultimately leading to the selective apoptosis of pro-inflammatory Th1 and Th17 effector T cells. This mechanism is a key checkpoint in immune tolerance; its dysfunction is linked to autoimmune disorders, while its exploitation by tumors facilitates immune evasion. Therapeutic interventions include Galectin-1 mimetics or agonists to suppress overactive immune responses in autoimmunity and Galectin-1 inhibitors to restore T cell activity in oncology. Additionally, therapeutic antibodies such as Siplizumab have been shown to induce T cell depletion by interacting with components of this lipid raft-associated complex.

Other names

GM1-associated integrinsGalectin-1 receptor complexGM1-LFA-1 complexGM1-alpha5beta1 complexLipid raft-associated integrin complex

Induction of selective apoptosis in effector T cells (Th1 and Th17) via Galectin-1-mediated cross-linking and redistribution of lipid raft components, or inhibition of this process to enhance anti-tumor immunity.